H.R.4144 - Ending the Diagnostic Odyssey Act of 2019116th Congress (2019-2020)
|Sponsor:||Rep. Peters, Scott H. [D-CA-52] (Introduced 08/02/2019)|
|Committees:||House - Energy and Commerce|
|Latest Action:||House - 08/05/2019 Referred to the Subcommittee on Health. (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
Summary: H.R.4144 — 116th Congress (2019-2020)All Information (Except Text)
Introduced in House (08/02/2019)
Ending the Diagnostic Odyssey Act of 2019
This bill allows state Medicaid programs to cover whole genome sequencing services for certain individuals.
Specifically, states may cover such services for individuals under the age of 21 (or a lower age, if the state chooses) and for former foster youth under the age of 26 who (1) have been referred or admitted to an intensive care unit or seen by a medical specialist for a suspected genetic or undiagnosed disease, or (2) are suspected by a medical specialist to have a neonatal- or pediatric-onset genetic disease.
The Centers for Medicare & Medicaid Services may award grants to assist states in developing plans to cover such services.